AmplifiDX Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$100K
- Investors
-
12
AmplifiDX General Information
Description
Developer of a molecular point-of-care device designed to provide rapid test results cost-effectively.The company's technology is engineered for fast turnaround and high sensitivity, otherwise only found in laboratory PCR tests a clear and actionable COVID-19 result, the system is linked to mobile devices, and it delivers results in as little as half an hour, enabling users to quickly isolate and stop the spread.
Contact Information
Website
www.amplifidx.comCorporate Office
- 39655 Eureka Drive
- Newark, CA 94560
- United States
Corporate Office
- 39655 Eureka Drive
- Newark, CA 94560
- United States
AmplifiDX Timeline
AmplifiDX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 15-Apr-2026 | $100K | Completed | Generating Revenue | ||
| 6. Later Stage VC | 01-Jun-2025 | Completed | Generating Revenue | |||
| 5. Grant | 10-Dec-2024 | Completed | Generating Revenue | |||
| 4. Grant | 15-May-2023 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 20-Aug-2021 | $2M | $2.33M | Completed | Generating Revenue | |
| 1. Angel (individual) | 22-Jul-2021 | $329K | $329K | Completed | Generating Revenue |
AmplifiDX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 38,156 | $0.000010 | $1.05 | $1.05 | 1x | $1.05 | 0.59% | |
| Seed-1 | 50,678 | $0.000010 | $0.99 | $0.99 | 1x | $0.99 | 0.78% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
AmplifiDX Patents
AmplifiDX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250389715-A1 | Point-of-care bioassay systems and methods of making and using the same | Pending | 24-Jun-2024 | ||
| WO-2026006318-A1 | Point-of-care bioassay systems and methods of making and using the same | Pending | 24-Jun-2024 |
AmplifiDX Signals
AmplifiDX Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beacon Angels | Angel Group | Minority | ||
| Femovate | Accelerator/Incubator | Minority | ||
| National Institute of Biomedical Imaging and Bioengineering | Government | |||
| National Institutes of Health | Government | |||
| Avestria Ventures | Venture Capital | Minority |
AmplifiDX FAQs
-
When was AmplifiDX founded?
AmplifiDX was founded in 2020.
-
Where is AmplifiDX headquartered?
AmplifiDX is headquartered in Newark, CA.
-
What is the size of AmplifiDX?
AmplifiDX has 3 total employees.
-
What industry is AmplifiDX in?
AmplifiDX’s primary industry is Diagnostic Equipment.
-
Is AmplifiDX a private or public company?
AmplifiDX is a Private company.
-
What is AmplifiDX’s current revenue?
The current revenue for AmplifiDX is .
-
How much funding has AmplifiDX raised over time?
AmplifiDX has raised $2.33M.
-
Who are AmplifiDX’s investors?
Beacon Angels, Femovate, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, and Avestria Ventures are 5 of 12 investors who have invested in AmplifiDX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process